ArticleNano letters2025
On a Continuous Aqueous Thermogalvanic Redox Agent with Anomalous Thermopower.
Article in Nano letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Buffered Hexacyanoferrate Electrolyte for Thermogalvanic Heat Harvesting across Symmetric and Asymmetric Electrode Configurations.ACS nano · 2026Article
- A bird's-eye view for future ionic thermoelectrics: from ions to products.National science review · 2026Review
- Polarity promotes power production.Nature reviews. Chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Achieving stable and sustained power output remains a major challenge in the development of ionic thermoelectric devices (such as thermogalvanic cells and thermoionic capacitors) for low-grade heat harvesting. Many such systems exhibit strong performance in the initial throes of operation but degrade rapidly over time, limiting their utility. Here, we report an aqueous thermogalvanic redox agent ([Ni(bpy)
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.